| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |